Mov Disord Vol 34, Suppl 2 Archives - Page 172 of 217 - MDS Abstracts

2019 International Congress
An examination of real-world onabotulinumtoxinA utilisation for the treatment of lower limb spasticity: The Adult Spasticity International Registry (ASPIRE) study
A. Esquenazi, W. Jost, G. Bavikatte, D. Bandari, M. Munin, A. Zuzek, A. Patel, J. Largent, G. Francisco (Elkins Park, PA, USA)
Objective: To explore real-world patterns of onabotulinumtoxinA utilisation in patients with lower limb spasticity over 2 years. Background: OnabotulinumtoxinA treatment for spasticity is variable as…
2019 International Congress
Structural Connectivity Predicts Clinical Outcomes of Deep Brain Stimulation for Tourette Syndrome
K. Johnson, G. Duffley, D. Servello, A. Bona, M. Porta, J. Ostrem, E. Bardinet, M-L. Welter, A. Lozano, J. Baldermann, J. Kuhn, D. Huys, T. Foltynie, M. Hariz, E. Joyce, L. Zrinzo, Z. Kefalopoulou, J-G. Zhang, F-G. Meng, CC. Zhang, Z. Ling, X. Xu, X. Yu, A. Smeets, L. Ackermans, V. Visser-Vandewalle, A. Mogilner, M. Pourfar, L. Almeida, A. Gunduz, W. Hu, K. Foote, M. Okun, C. Butson (Salt Lake City, UT, USA)
Objective: The objective of this study was to identify the structural connectivity correlates of improvement in tics and obsessive-compulsive behavior (OCB) following deep brain stimulation…
2019 International Congress
Orthostatic tremor – a case series
L. Colmenares, L. Jones, Y. Tai, P. Bain (London, United Kingdom)
Objective: To study the clinical characteristics of a large single-centre cohort of patients with Orthostatic Tremor (OT) Background: OT is a rare but disabling condition…
2019 International Congress
Holmes Tremor : contribution of Botulinum toxin injection strategy guided by electromyographic (EMG) polygraphic recording
F. Jomier, Y. Beaugendre Ahmar, E. Apartis, D. Grabli (Paris, France)
Objective: To show that botulinum toxin injections guided by EMG polygraphic recording is effective to improve proximal upper limbs tremor. Background: Holmes tremor is highly disabling,…
2019 International Congress
Improvement of Essential Tremor after Cortical Cerebral Infarction
D. Riley (Warrensville Heights, OH, USA)
Objective: To report a case of resolution of contralateral essential tremor (ET) after a cerebral cortical infarction. The restricted nature of the clinical and radiologic findings…
2019 International Congress
Tremoroton, a new open source tool for tremor analysis
F. Vial, P. Kassavetis, M. Hallett (Bethesda, MD, USA)
Objective: To introduce an open source software for the electrophysiological analysis of tremor. Background: The last MDS consensus on tremor in 2018 proposed a tremor…
2019 International Congress
Long-Term Outcomes with Valbenazine 40 mg/day in Adults with Tardive Dyskinesia
S. Marder, C. Comella, C. Singer, C. Chepke, J. Burke, K. Farahmand, S. Siegert (Los Angeles, CA, USA)
Objective: To examine long-term outcomes in adults with tardive dyskinesia (TD) who received once-daily valbenazine (VBZ) 40 mg or had a dose reduction from 80…
2019 International Congress
Subthalamic Nucleus of Luys: A review. What has evolved since 1865?
G. Froehner, A. Meira, F. Germiniani, M. Meneses, R. Munhoz, H. Teive (Curitiba, Brazil)
Objective: The review provides detailed material about the Subthalamic Nucleus of Luys, including pathophisiolgy, hystorical notes about Luys, embryology, anatomy, principal afferents and efferents pathways, as…
2019 International Congress
The effect of dopaminergic therapy on functional connectivity in patients with Parkinson’s disease and visual hallucinations
A. Powell, J. Shine, S. Lewis (Sydney, Australia)
Objective: To examine changes in functional connectivity in patients with Parkinson’s disease (PD) and visual hallucinations (VH) on and off dopaminergic medication. Background: Symptoms on…
2019 International Congress
Autonomic dysfunction in early Parkinson’s disease: a prospective study
I. Stankovic, I. Petrovic, T. Pekmezovic, V. Markovic, T. Stojkovic, N. Dragasevic Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)
Objective: To define prevalence, severity, and predictors of dysautonomia symptoms in patients with Parkinson's disease (PD) recruited at the Hoehn and Yahr stage 1 prospectively followed for three years.…